Bluebird bio (BLUE) Stock Highlights

0.99 | -3.88%

2024-04-17 02:48:17

bluebird bio Inc is a clinical-stage biotechnology company that develops gene therapies for severe genetic and rare diseases. The companys gene therapy procedures aim to genetically modify a patients cells to fundamentally correct or address the genetic basis underlying a disease. Bluebirds revenue is derived from collaboration arrangements, research fees, license fees, and grant revenue. The company works with industry peers, strategic partners, and nonprofit organizations for the development and commercialization of its product candidates.

Statistics

Range Today

0.98 1.07

Volume Today 5.88M

Range 1 Year

0.88 5.53

Volume 1 Year 1.73B

Range 3 Year

0.88 35.59

Volume 3 Year 3.63B

Range 10 Year

0.88 236.17

Volume 10 Year 5.33B

Highlights

Market Capitalization 212.02M (small)

Floating Shares 108.82M

Current Price 0.99

Price To Earnings -1.83

Price To Revenue 11.49

Price To Book 0.53

Earnings Per Share -0.63

Payout Ratio 0%

Performance

Latest -3.88%

1 Month -31.72%

3 Months -33.56%

6 Months -63.06%

1 Year -68.97%

3 Years -96.62%

5 Years -99.36%

10 Years -95.17%

Benchmarks

Market Capitalization

191 / 377

Gross Profits

272 / 285

Total Revenue

163 / 309

Total Rank

280 / 377

Free Cashflow

308 / 361

Performance 5 years

370 / 377

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.